Clinical trial

Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in…

NCT00415766 · Eugonia, Other · Unknown status

Key facts

NCT number NCT00415766
Title Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders
Official title Recombinant hCG (Ovitrelle) Vesrus Urinary hCG (Pregnyl) for Triggering Final Oocyte Maturation in High Responders
Lead sponsor Eugonia, Other
Status Unknown status
Phase Phase 4
Study type Interventional
Conditions Infertility
Intervention type Drug
Interventions rHCG 250ug, uHCG 5000 IU, uHCG 7500 IU
Enrollment 150
Start date Jun 1, 2013
Primary completion Dec 1, 2015
Completion Jul 1, 2016
First posted Dec 25, 2006
Last update posted Jan 20, 2016
Countries Greece

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies